The TH2 immune response is crucial in the development of AD, involving type-2 cytokines like interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-13 (IL-13), and interleukin-31 (IL-31) [2]. This evidence concerns the gene IL31 and Alzheimer disease.